Click on headlines below to download research

Continued execution of footprint expansion
AFT Pharmaceuticals | 10/07/2024

AFT Pharmaceuticals continues to make inroads in expanding its strategic market footprint. Most recently, it announced the entry into China with the distribution…

...read more

Growth underpinned by international momentum
AFT Pharmaceuticals | 23/05/2024

AFT Pharmaceuticals’ FY24 results demonstrated record earnings and sales, with 24.8% year-on-year sales growth. Revenues of NZ$195.4m were driven…

...read more

Maxigesic IV’s Brazil entry, a foray into LATAM
AFT Pharmaceuticals | 02/05/2024

AFT continues to expand its Maxigesic IV footprint with the announcement of a licensing agreement in Brazil, the largest pharma market in South America…

...read more